Indoco wins major tenders in Germany for Allopurinol Tablets

▴ Indoco wins major tenders in Germany for Allopurinol Tablets
Indoco manufactures Allopurinol API at its new API manufacturing site at Patalganga.

Indoco Remedies announced today that it won major tenders worth Rs. 140 cr. in Germany, including the AOK for Allopurinol Tablets. The revenue expected from this business is Rs. 70 cr. per annum. The supplies to Germany will begin from January 2021 and continue till end of 2022. API consumption will be approx. 100 metric tons per year for this supply.

Indoco manufactures Allopurinol API at its new API manufacturing site at Patalganga. The new API site has a capacity to manufacture 25 tons of Allopurinol per month or 300 tons annually.

Commenting on this development, Ms. Aditi Kare Panandikar, Managing Director - Indoco Remedies Ltd. said, “This is Indoco's first own label product in Europe. Germany is totally tender business and Indoco has won almost 80 - 85% tenders for Allopurinol. This is a tender order for supplies spread over two years and if we are competitive, we may get repeat orders when the tenders are floated after two years. We believe, because of backward integration, we will remain competitive and completely in control of supplies.”

Tags : #LatestPharmaNewsDec8 #LatestIndocoNewsDec8 #Treatmentforuricacid #treatmentforkidneystones

About the Author


Sana Farid Khan

“The best way to become acquainted with a subject is to write about it."
A confident counselor, a speaker, and an educator, ready to utilize my communication skills effectively in the world of healthcare by putting pen to paper to reach new heights of success.
You can write to me at [email protected]

Related Stories

Loading Please wait...